|
EIF2S1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.910600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.244300E-02 |
| Normal-vs-Stage2 |
9.027800E-01 |
| Normal-vs-Stage3 |
2.256200E-01 |
| Normal-vs-Stage4 |
8.544400E-01 |
| Stage1-vs-Stage2 |
1.352830E-01 |
| Stage1-vs-Stage3 |
4.715500E-03 |
| Stage1-vs-Stage4 |
2.699200E-01 |
| Stage2-vs-Stage3 |
4.430400E-01 |
| Stage2-vs-Stage4 |
9.314400E-01 |
| Stage3-vs-Stage4 |
6.002400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.958000E-01 |
| Normal-vs-AfricanAmerican |
9.856300E-02 |
| Normal-vs-Asian |
8.925200E-01 |
| Caucasian-vs-AfricanAmerican |
2.101800E-02 |
| Caucasian-vs-Asian |
7.994600E-01 |
| AfricanAmerican-vs-Asian |
5.474400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.209800E-01 |
| Normal-vs-Female |
3.674400E-01 |
| Male-vs-Female |
4.786200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.922800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.386600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.032600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.429200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.294200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.485000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.303200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.758600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.769400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.572000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.421700E-03 |
| Normal-vs-Grade 2 |
1.322450E-02 |
| Normal-vs-Grade 3 |
2.195200E-01 |
| Normal-vs-Grade 4 |
4.431600E-01 |
| Grade 1-vs-Grade 2 |
1.924160E-01 |
| Grade 1-vs-Grade 3 |
1.088360E-02 |
| Grade 1-vs-Grade 4 |
1.890260E-02 |
| Grade 2-vs-Grade 3 |
1.637530E-04 |
| Grade 2-vs-Grade 4 |
6.327600E-02 |
| Grade 3-vs-Grade 4 |
8.354200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.793000E-04 |
| Normal-vs-ccB subtype |
1.133400E-01 |
| ccA subtype-vs-ccB subtype |
2.25109999973938E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.536600E-01 |
| Normal-vs-N1 |
3.658900E-03 |
| N0-vs-N1 |
1.317720E-02 |
|
|
